Tamara Kalechman Hatav, Director of Global Relations & Partnerships at Sheba Medical Center, shared Sheba Medical Centre’s post on LinkedIn, adding:
“Proud to see Prof. Yitshak Kreiss recognized by OncoDaily as one of the 100 Most Influential CEOs in Oncology in 2025. This is a meaningful recognition of his leadership and Sheba Medical Center, Tel Hashomer’s ongoing commitment to advancing cancer care globally.”
Quoting Sheba Medical Centre‘s post:
“We are proud to share that Prof. Yitshak Kreiss, Director General of Sheba, has been named one of The 100 Most Influential CEOs in Oncology in 2025 by OncoDaily.
The list recognizes chief executives whose leadership has had a measurable and lasting impact on the global oncology ecosystem, influencing cancer research, care delivery, and patient outcomes.
Under Prof. Kreiss’s leadership, Sheba has advanced its vision as a City of Health, integrating clinical care, research, and advanced infrastructure within a single academic medical center. This approach is reflected in the work of the Jusidman Cancer Center, Sheba’s CAR-T research program, and the Roman Abramovich Theranostics and Nuclear Medicine Center, where research and clinical care take place alongside on-site isotope production.
To learn more about this recognition and what it represents at an institutional level, read the full article”
More posts on OncoDaily